CLINICAL TRIALS PROFILE FOR LICART
✉ Email this page to a colleague
All Clinical Trials for LICART
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05171673 ↗ | Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury | Recruiting | IBSA Institut Biochimique SA | Phase 3 | 2021-10-31 | A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety of the LicartTM topical system in pediatric and adult participants with minor soft tissue injuries. 150 male and female participants aged 6-16 and 18-45 with soft tissue injuries meeting the following criteria will be enrolled to evaluate the pharmacokinetics and safety of the Licart topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. The analgesic effects will also be evaluated of the topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. To collect principal investigator-reported global response to therapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LICART
Condition Name
Clinical Trial Locations for LICART
Trials by Country
Clinical Trial Progress for LICART
Clinical Trial Phase
Clinical Trial Sponsors for LICART
Sponsor Name